Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Celgene
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients aged ≥ 18 years.
Patients diagnosed with metastatic pancreatic cancer confirmed histologically or cytologically
Patients with Karnofsky index ≥ 70 previously untreated with chemotherapy.
Patients with life expectancy ≥ 6 months.
Patients who will be treated with chemotherapy as first-line treatment for metastatic pancreatic cancer.\*
Informed consent in writing or orally before witnesses.
* The decision to prescribe any treatment will be clearly dissociated from the patient's inclusion in the study. Therefore, the choice of therapeutic strategy will be made according to usual clinical practice and independently by the doctor before assessing the possible involvement of the patients in the study and their corresponding inclusion in it
You may not be if
Pregnant or breastfeeding.
Patients who are participating in an interventional clinical trial.
Patients who refuse to participate in this study.
Patients who have no ability to understand and respond to questions related to their health.
Clareo Health | Observational Study of Quality of Live in Patients With Metastatic Pancreatic Cancer
